Molecular Partners AG ADR (MOLN) — Capital Reinvestment Ratio
Molecular Partners AG ADR (MOLN) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($163.56 Million) in capital expenditures ($380.00K). See MOLN net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Molecular Partners AG ADR Capital Reinvestment Ratio (2015–2022)
This chart tracks Molecular Partners AG ADR's Capital Reinvestment Ratio across 2 annual periods. Check cash flow reinvestment rate of Molecular Partners AG ADR to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Molecular Partners AG ADR (2015–2022)
Year-by-year Capital Reinvestment Ratio for Molecular Partners AG ADR from 2015 to 2022. For live market cap and broader valuation context, see market cap of Molecular Partners AG ADR.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | $118.57 Million | $1.42 Million | ▼ -77.2% |
| 2015 | 0.05x | $26.50 Million | $1.39 Million | — |